Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Sagimet Biosciences to Participate in the Piper Sandler 36th Annual Healthcare Conference
-
PharmaTher Announces Update on FDA New Drug Application for Ketamine
-
Equipment Leasing and Finance Association CapEx Finance Index: October 2024
-
ASP Isotopes Inc. Completes Construction and Starts the Commissioning of Silicon-28 Enrichment Facility
-
Vertex Holiday Shopping Survey Emphasizes the Crucial Role of Tax Automation
-
Brane Audio Unveils New Lower Price for Brane X Speaker, Now Available on Amazon Prime
-
Teledyne launches Z-Trak 3D Apps Studio software tools for in-line 3D measurement and inspection
-
SeaStar Medical to Present at Noble Capital Markets’ NobleCon20 on December 4, 2024
-
Freshworks to Participate in UBS Global Technology Conference
-
Leading Sustainable Asphalt Producer SteelPhalt™ Unveils New Brand Identity
-
Lexicon Announces Completion of Enrollment in Phase 2B PROGRESS Study of LX9211 in Diabetic Peripheral Neuropathic Pain (DPNP)
-
Eos Energy signs MOU with Wabash to Dramatically Accelerate the Supply Chain Ecosystem for American Made Energy Storage Solutions
-
Solid Biosciences to Participate at Upcoming Investor Conferences
-
Gentex Announces Fourth Quarter 2024 Cash Dividend
-
Cabaletta Bio to Participate in Upcoming Investor Conferences in December
-
Aligos Therapeutics to Present at Investor Conferences in December
-
Otsuka Submits New Drug Application in Japan for Bempedoic Acid in the Treatment of Hypercholesterolemia
-
Scatec ASA: Mandatory notification of trade by primary insider
-
Medigene AG Announces Refocus of Corporate Strategy and Organizational Realignment
-
Renexxion Ireland Ltd. Announces Issuance of Fifth New U.S. Patent Covering Novel Crystal Isoform of Naronapride
-
Form 8.3 - Learning Technologies Group Plc
-
Form 8.3 - [BENCHMARK HOLDINGS PLC - 25 11 2024] - (CGAML)
-
ParaZero Partners with Drone Nerds to Expand SafeAir Systems Reach Across North America
-
Bybit Launches bbSOL Virtual Card, Bridging Solana Ecosystem with Innovative Features
-
Form 8.3 - [LEARNING TECHNOLOGIES GROUP PLC - 25 11 2024] - (CGWL)
-
BriaCell 2024 SABCS® Spotlight Poster to Showcase Positive Overall Survival Data Across All Patient Subtypes in Metastatic Breast Cancer
-
Profound Medical to Unveil Next TULSA-AI® Module, ‘UA Alignment Assistant’
-
Form 8.3 - [VOLEX PLC - 25 11 2024] - (CGWL)
-
Abercrombie & Fitch Co. Appoints Robert Ball as Chief Financial Officer
-
Abercrombie & Fitch Co. Appoints Robert Ball as Chief Financial Officer
-
Sylogist Announces Renewal of its NCIB
-
Cognition Therapeutics Announces all Participants have Completed their Final Visits in the Phase 2 SHIMMER Study of CT1812 in Dementia with Lewy Bodies
-
Electra Completes US$5 Million Financing and Settles Accrued Interest on Convertible Notes
-
Prime Drink Group Enters Into Letter of Intent to Acquire Beach Day Every Day
-
Ocular Therapeutix™ to Participate in December Investor and Scientific Conferences
-
Abercrombie & Fitch Co. Reports Third Quarter Fiscal 2024 Results
-
Purpose Investments Inc. Announces Final November 2024 Distribution Rate for Purpose High Interest Savings Fund, Purpose US Cash Fund, Purpose Cash Management Fund, and Purpose USD Cash Management Fu
-
SL Green Announces Acquisition of 500 Park Avenue
-
ProKidney to Participate in Two Upcoming Conferences: Evercore HealthCONx Conference and the Citi Global Healthcare Conference
-
Kelly Announces Completion of CFO Transition, Participation in Sidoti Virtual Investor Conference
-
NeuroNOS Appoints Nobel Laureate, Roger D. Kornberg, to Scientific Advisory Board
-
Altimmune to Participate at Two Upcoming Investor Conferences
-
DeFi Technologies’ Subsidiary Valour Launches First Dogecoin (DOGE) ETP in the Nordics on Spotlight Stock Market
-
Abercrombie & Fitch Co. Reports Third Quarter Fiscal 2024 Results
-
LeddarTech Fortifies Its Cybersecurity Framework with ISO/IEC 27001 Certification
-
Theratechnologies Submits Updated Tesamorelin F8 Formulation sBLA for FDA Review
-
Zevra Therapeutics to Participate at Upcoming Investor Conferences
-
Anavex Life Sciences Announces Submission of Blarcamesine MAA for Treatment of Alzheimer’s Disease to EMA
-
Arbutus to Participate in H.C Wainwright @ Home Virtual Fireside Chat
-
The Joint Corp. to Participate in the 13th Annual ROTH Deer Valley Event

